Patient selection for carotid endarterectomy: How far is risk modeling applicable to the individual?

Stroke

Volumn 34, Issue 2, 2003, Pages 524-527

  Barth, Alain ^a   Bassetti, Claudio ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Carotid endarterectomy; Carotid stenosis; Patient selection; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; CAROTID ENDARTERECTOMY; DISEASE MODEL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INDIVIDUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROBLEM SOLVING; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SYMPTOMATOLOGY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 0037319243     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000051729.79990.FB     Document Type: Article

References (21)

1. ECST Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
2. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
3. North American Symptomatic Carotid Endarterectomy Trialists' Collaborative Group. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325: 445-453.
4. Mayberg MR, Wilson SE, Yatsu F, Weiss DG, Messina L, Hershey LA, Colling C, Eskridge J, Deykin D, Winn HR. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis: Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991; 266:3289-3294.
5. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339: 1415-1425.
6. Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett HJ. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke. 1999;30:1751-1758.
7. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000;343: 317-326.
8. Moore WS, Barnett HJ, Beebe HG, Bernstein EF, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW 2nd, et al. Guidelines for carotid endarterectomy: a multidisciplinary consensus statement from the ad hoc committee, American Heart Association. Stroke. 1995;26:188-201.
9. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, Caplan LR, Kresowik TF, Matchar DB, Toole J, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1998;29:554-562.
10. Rothwell PM, Warlow CP, for the European Carotid Surgery Trialists' Collaborative Group. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. Lancet. 1999;353:2105-2110.
11. Dietz A, Berkefeld J, Theron JG, Schmitz-Rixen T, Zanella FE, Turowski B, Steinmetz H, Sitzer M. Endovascular treatment of symptomatic carotid stenosis using stent placement: long-term follow-up of patients with a balanced surgical risk/benefit ratio. Stroke. 2001;32:1855-1859.
12. Remonda L, Held O, Schroth G. Carotid artery stenosis, occlusion, and pseudo-occlusion: first-pass, gadolinium-enhanced, three-dimensional MR angiography: preliminary study. Radiology. 1998;209:95-102.
13. Remonda L, Senn P, Barth A, Arnold M, Lövblad KO, Schroth G. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol. 2002;23:213-219.
14. Barth A, Lukes A, Remonda L, Mattle H, Seiler RW. Ergebnisse und Stellenwert der Karotisthrombendarterektomie. Schweiz Med Wochenschr. 2000;130:1062-1071.
15. Barth A, Remonda L, Lövblad KO, Schroth G, Seiler RW. Silent cerebral ischemia detected by diffusion-weighted MRI after carotid endarterectomy. Stroke. 2000;31:1824-1828.
16. Barnett HJM, Eliasziw M, Meldrum HE, Taylor DW. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology. 1996;46:603-608.
17. Wong JH, Findlay JM, Suarez-Almazor ME. Regional performance of carotid endarterectomy: appropriateness, outcomes, and risk factors for complications. Stroke. 1997;28:891-898.
18. Goldstein LB, Moore WS, Robertson JT, Chaturvedi S. Complication rates for carotid endarterectomy: a call to action. Stroke. 1997;28: 889-890.
19. Gorelick PB. Carotid endarterectomy: where do we draw the line? Stroke. 1999;30:1745-1750.
20. Barnett HJM, Broderick JP. Carotid endarterectomy: another wake-up call. Neurology. 2000;55:746-747.
21. Chaturvedi S, Aggarwal R, Murugappan A. Results of carotid endarterectomy with prospective neurologist follow-up. Neurology. 2000;55:769-772.